People | June 04, 2026
Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The Japanese Patent Office has issued a favorable Appeal Decision granting a patent for the use of REQORSA Gene Therapy in combination with PD-L1 antibodies to treat cancer
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
